Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,878 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Socioeconomic Factors and Survival of Multiple Myeloma Patients.
Chamoun K, Firoozmand A, Caimi P, Fu P, Cao S, Otegbeye F, Metheny L, Patel S, Gerson SL, Boughan K, De Lima M, Malek E. Chamoun K, et al. Among authors: fu p. Cancers (Basel). 2021 Feb 3;13(4):590. doi: 10.3390/cancers13040590. Cancers (Basel). 2021. PMID: 33546206 Free PMC article.
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
Wadhwa PD, Fu P, Koc ON, Cooper BW, Fox RM, Creger RJ, Bajor DL, Bedi T, Laughlin MJ, Payne J, Gerson SL, Lazarus HM. Wadhwa PD, et al. Among authors: fu p. Biol Blood Marrow Transplant. 2005 Jan;11(1):13-22. doi: 10.1016/j.bbmt.2004.09.003. Biol Blood Marrow Transplant. 2005. PMID: 15625540 Free article. Clinical Trial.
Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.
van Heeckeren WJ, Vollweiler J, Fu P, Cooper BW, Meyerson H, Lazarus HM, Simic A, Laughlin MJ, Gerson SL, Koç ON. van Heeckeren WJ, et al. Among authors: fu p. Br J Haematol. 2006 Jan;132(1):42-55. doi: 10.1111/j.1365-2141.2005.05827.x. Br J Haematol. 2006. PMID: 16371019 Free article. Clinical Trial.
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial.
Batts ED, Maisel C, Kane D, Liu L, Fu P, O'Brien T, Remick S, Bahlis N, Gerson SL. Batts ED, et al. Among authors: fu p. Cancer Chemother Pharmacol. 2007 Aug;60(3):415-21. doi: 10.1007/s00280-007-0442-7. Epub 2007 Mar 13. Cancer Chemother Pharmacol. 2007. PMID: 17354015 Clinical Trial.
Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts.
Lazarus HM, Sommers SR, Arfons LM, Fu P, Ataergin SA, Kaye NM, Liu F, Kindwall-Keller TL, Cooper BW, Laughlin MJ, Creger RJ, Barr PM, Gerson SL, Kaplan D. Lazarus HM, et al. Among authors: fu p. Biol Blood Marrow Transplant. 2011 Jul;17(7):970-8. doi: 10.1016/j.bbmt.2011.03.005. Epub 2011 Apr 11. Biol Blood Marrow Transplant. 2011. PMID: 21440080 Free article.
Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.
Apisarnthanarax N, Wood GS, Stevens SR, Carlson S, Chan DV, Liu L, Szabo SK, Fu P, Gilliam AC, Gerson SL, Remick SC, Cooper KD. Apisarnthanarax N, et al. Among authors: fu p. Arch Dermatol. 2012 May;148(5):613-20. doi: 10.1001/archdermatol.2011.2797. Arch Dermatol. 2012. PMID: 22250189 Free PMC article. Clinical Trial.
2,878 results